L-DOPA Decarboxylase Association with Membranes in Mouse Brain

被引:0
|
作者
Poulikos Poulikakos
Dido Vassilacopoulou
Emmanuel G. Fragoulis
机构
[1] University of Athens,Department of Biochemistry and Molecular Biology
来源
Neurochemical Research | 2001年 / 26卷
关键词
L-DOPA decarboxylase; mouse brain; membranes; Triton X-114; phosphatidylinositol-specific phospholipase C;
D O I
暂无
中图分类号
学科分类号
摘要
This work presents evidence on the association of active DDC molecules with membranes in mammalian brain. L-DOPA decarboxylase (DDC) is generally considered to be a cytosolic enzyme. Membrane-associated DDC was detected by immunoblotting and enzymatic assay experiments. DDC activity and immunoreactivity could be partially extracted from mammalian brain membranes by detergent. Fractionation of membranes by temperature-induced phase separation in Triton X-114, resulted in the recovery of membrane-associated DDC in separation phases where integral and hydrophobic membrane proteins separate. Treatment of membranes with phosphatidylinositol-specific phospholipase C or proteinase K, did not elute membrane-associated DDC activity, suggesting that a population of DDC molecules exist embedded within membranes. The elucidation of the functional significance of the enzyme's association with membranes could provide us with new information leading to the better understanding of the biological pathways that DDC is involved in.
引用
收藏
页码:479 / 485
页数:6
相关论文
共 50 条
  • [31] MONITORING OF BLOOD DOPA LEVELS DURING ADMINISTRATION OF L-DOPA AND INHIBITORS OF DOPA DECARBOXYLASE
    ROYER, RJ
    KISSEL, P
    HUMBERT, F
    NETTER, P
    ROYERMORROT, MJ
    JOURNAL DE PHARMACOLOGIE, 1975, 6 (03) : 365 - 366
  • [32] TRIHYDRATE STRUCTURE OF A MULTISUBSTRATE INHIBITOR OF L-DOPA DECARBOXYLASE
    GULBIS, JM
    MACKAY, MF
    ILES, MM
    ISKANDER, MN
    ANDREWS, PR
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1990, 46 : 1665 - 1668
  • [33] Cloning and Expression of Human Placental L-Dopa Decarboxylase
    Maria-Zaharenia Siaterli
    Dido Vassilacopoulou
    Emmanuel G. Fragoulis
    Neurochemical Research, 2003, 28 : 797 - 803
  • [34] INVIVO ASSESSMENT OF DECARBOXYLASE INHIBITION OR POTENTIATION - URINARY DOPAMINE AND L-DOPA OUTPUT AFTER L-DOPA ADMINISTRATION
    JOHNSON, RD
    RUTHVEN, CRJ
    GOODWIN, BL
    SANDLER, M
    JOURNAL OF NEURAL TRANSMISSION, 1976, 38 (3-4) : 181 - 191
  • [35] Solubilization of membrane-bound L-dopa decarboxylase
    Tsiropoulou, S.
    Fragoulis, E.
    Vassilacopoulou, D.
    FEBS JOURNAL, 2008, 275 : 322 - 322
  • [36] ORIGIN OF 5-HYDROXYTRYPTOPHAN AND L-DOPA ACCUMULATING IN BRAIN FOLLOWING DECARBOXYLASE INHIBITION
    BEDARD, P
    FUXE, K
    LINDQVIST, M
    CARLSSON, A
    NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1971, 269 (01): : 1 - +
  • [37] TREATMENT OF IDIOPATHIC PARKINSONISM WITH L-DOPA IN THE ABSENCE AND PRESENCE OF DECARBOXYLASE INHIBITORS - EFFECTS ON PLASMA-LEVELS OF L-DOPA, DOPA DECARBOXYLASE, CATECHOLAMINES AND 3-O-METHYL-DOPA
    BOOMSMA, F
    MEERWALDT, JD
    INTVELD, AJM
    HOVESTADT, A
    SCHALEKAMP, MADH
    JOURNAL OF NEUROLOGY, 1989, 236 (04) : 223 - 230
  • [38] METABOLISM OF L-DOPA IN PIGTAIL MONKEY - EFFECT OF A-DOPA DECARBOXYLASE INHIBITOR
    BRONAUGH, RL
    WENGER, GR
    GARVER, DL
    RUTLEDGE, CO
    PHARMACOLOGIST, 1974, 16 (02): : 236 - 236
  • [39] TREATMENT OF SYDENHAMS CHOREA WITH A COMBINATION OF L-DOPA AND A PERIPHERAL DOPA DECARBOXYLASE INHIBITOR
    SPISSU, A
    CORSINI, GU
    MARROSU, F
    MANGONI, A
    GESSA, GL
    PSYCHOPHARMACOLOGIA, 1975, 44 (03): : 311 - 312
  • [40] TREATMENT OF PARKINSONISM BY L-DOPA AND DOPA-DECARBOXYLASE INHIBITOR IN A SINGLE TABLET
    SAROVAPI.I
    BRAHAM, J
    HAREFUAH, 1974, 87 (05) : 208 - 210